Exhibit 4.10
THIS WARRANT HAS BEEN, AND THE SHARES OF COMMON STOCK WHICH MAY BE RECEIVED
PURSUANT TO THE EXERCISE OF THIS WARRANT WILL BE, ACQUIRED SOLELY FOR INVESTMENT
AND NOT WITH A VIEW TO, OR FOR RESALE IN CONNECTION WITH, ANY DISTRIBUTION
THEREOF. NEITHER THIS WARRANT NOR SUCH SHARES (TOGETHER, THE "SECURITIES") HAVE
BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE "ACT"), OR ANY
STATE SECURITIES LAWS. SUCH SECURITIES MAY NOT BE SOLD, OFFERED FOR SALE,
PLEDGED OR HYPOTHECATED IN THE ABSENCE OF SUCH REGISTRATION OR AN OPINION OF
COUNSEL REASONABLY SATISFACTORY TO THE COMPANY THAT SUCH DISPOSITION IS EXEMPT
FROM THE REGISTRATION AND PROSPECTUS DELIVERY REQUIREMENTS OF THE ACT AND OF ANY
APPLICABLE STATE SECURITIES LAWS.
NO. WA1- ISSUED: APRIL 8, 2004
A-1 WARRANT TO PURCHASE COMMON STOCK
----------
THIS CERTIFIES THAT, for good and valuable consideration, ___________ (the
"HOLDER") is entitled to purchase from Adventrx Pharmaceuticals, Inc., a
Delaware corporation (the "COMPANY"), [30% COVERAGE]_______________ (________)
fully paid and nonassessable shares of Common Stock, par value $0.001 per share
("COMMON STOCK"), of the Company (as adjusted pursuant to Section 3 hereof) (the
"WARRANT SHARES") at a price per share equal to Two Dollars ($2.00) (as adjusted
pursuant to Section 3 hereof) (the "EXERCISE PRICE"), subject to the provisions
and upon the terms and conditions hereinafter set forth.
1. METHOD OF EXERCISE; PAYMENT.
(a) Exercise Period. The purchase right represented by this Warrant
may be exercised in whole or part by the Holder during the term of this
Warrant (as set forth in Section 9 hereof) at any time after the
Commencement Date, as defined below, by the surrender of this Warrant
(with the notice of exercise form attached hereto as Exhibit A (the
"NOTICE OF EXERCISE") duly executed) at the principal office of the
Company. If this Warrant shall have been exercised in part, the Company
shall, at the time of delivery of the certificate or certificates
representing Warrant Shares, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unpurchased shares of
Common Stock called for by this Warrant, which new Warrant shall in all
other respects be identical with this Warrant, or at the request of the
Holder, appropriate notation may be made on this Warrant and the same
returned to the Holder.
(b) Exercise. Upon exercise of this Warrant, the Holder shall pay
the Company an amount equal to the product of (x) the Exercise Price
multiplied by (y) the total number of Warrant Shares purchased pursuant to
this Warrant, by wire transfer or certified check payable to the order of
the Company -- or, at any time following the first anniversary of the
Warrant Date, if there is not an effective Registration Statement (as
defined in the Registration Rights Agreement) with respect to all of the
Warrant Shares, then at the option of the Holder, such amount may be paid
by the surrender of a portion of shares of Common Stock then held by the
Holder or issuable upon such exercise of this Warrant, which shall be
valued and credited toward such amount due to the Company for the exercise
of the Warrant based upon the Current Market Price of the Common Stock.
The person or persons in whose name(s) any certificate(s) representing the
Warrant Shares shall be issuable upon exercise of this Warrant shall be
deemed to have become the holder(s) of record of, and shall be treated for
all purposes as the record holder(s) of, the Warrant Shares represented
thereby (and such Warrant Shares shall be deemed to have been issued)
immediately prior to the close of business on the date upon which this
Warrant is exercised.
"CURRENT MARKET PRICE" means, in respect of any share of Common
Stock on any date herein specified,
(1) if there shall not then be a public market for the Common Stock,
the higher of
(a) the book value per share of Common Stock at such date, and
(b) the value per share of Common Stock at such date as
determined in good faith by the Board,
or
(2) if there shall then be a public market for the Common
Stock, the higher of (x) the book value per share of Common Stock at
such date, and (y) the average of the daily market prices for the 10
consecutive trading days immediately before such date. The daily
market price (the "DAILY MARKET PRICE") for each such trading day
shall be (i) the closing price on such day on the principal stock
exchange (including Nasdaq) on which such Common Stock is then
listed or admitted to trading, or quoted, as applicable, (ii) if no
sale takes place on such day on any such exchange, the last reported
closing price on such day as officially quoted on any such exchange
(including Nasdaq), (iii) if the Common Stock is not then listed or
admitted to trading on any stock exchange, the last reported closing
bid price on such day in the over-the-counter market, as furnished
by the National Association of Securities Dealers Automatic
Quotation System or the National Quotation Bureau, Inc., (iv) if
neither such corporation at the time is engaged in the business of
reporting such prices, as furnished by any similar firm then engaged
in such business, or (v) if there is no such firm, as furnished by
any member of the National Association of Securities Dealers, Inc.
(the "NASD") selected mutually by the holder of this Warrant and the
Company or, if they cannot agree upon such selection, as selected by
two such members of the NASD, one of which shall be selected by
holder of this Warrant and one of which shall be selected by the
Company.
(c) Stock Certificates. In the event of the exercise of this
Warrant, certificates for the Warrant Shares so purchased shall be
delivered to the Holder within a reasonable time after exercise, but
in no case later than the date that is three business days following
receipt by the Company of a Notice of Exercise duly completed and
executed.
2. STOCK FULLY PAID; RESERVATION OF SHARES. All of the Warrant Shares
issuable upon the exercise of the rights represented by this Warrant will,
upon issuance and receipt of the Exercise Price therefor, be fully paid
and nonassessable, and free from all preemptive rights, rights of first
refusal or first offer, taxes, liens and charges with respect to the
issuance thereof. During the period within which the rights represented by
this Warrant may be exercised, the Company shall at all times have
authorized and reserved for issuance a sufficient number of shares of its
Common Stock to provide for the exercise of the rights represented by this
Warrant.
-2-
3. ADJUSTMENT OF EXERCISE PRICE AND NUMBER OF SHARES. The number and kind
of Warrant Shares purchasable upon the exercise of this Warrant and the
Exercise Price therefor shall be subject to adjustment from time to time
upon the occurrence of certain events, as follows:
(a) Reclassification, Consolidation or Reorganization. In case of
any reclassification of the Common Stock (other than a change in par
value, or as a result of a subdivision or combination), or in case of any
consolidation or merger of the Company with or into another corporation
(other than a Change of Control, as defined below) (any of which is a
"REORGANIZATION TRANSACTION"), the Company, or such successor corporation
as the case may be, shall execute a new warrant, providing that the Holder
shall have the right to exercise such new warrant, and procure upon such
exercise and payment of the same aggregate Exercise Price, in lieu of the
Warrant Shares theretofore issuable upon exercise of this Warrant, the
kind and amount of shares of stock, other securities, money and property
as would be payable for the Warrant Shares issuable upon exercise of this
Warrant as if such Warrant Shares were outstanding on the consummation of
the Reorganization Transaction. For purposes of this Warrant, the term
"CHANGE OF CONTROL" shall mean (i) any acquisition of the Company by means
of merger, acquisition, or other form of corporate reorganization in which
outstanding shares of the Company are exchanged for securities or other
consideration issued, or caused to be issued, by the acquiring corporation
or its subsidiary or parent (other than a reincorporation transaction or
change of domicile) and pursuant to which the holders of the outstanding
voting securities of the Company immediately prior to such consolidation,
merger or other transaction fail to hold equity securities representing a
majority of the voting power of the Company or surviving entity
immediately following such consolidation, merger or other transaction
(excluding voting securities of the acquiring corporation held by such
holders prior to such transaction) or (ii) a sale of all or substantially
all of the assets of the Company.
(b) Stock Splits, Dividends and Combinations. In the event that the
Company shall at any time subdivide the outstanding shares of Common
Stock, or shall issue a stock dividend on its outstanding shares of Common
Stock, the number of Warrant Shares issuable upon exercise of this Warrant
immediately prior to such subdivision or to the issuance of such stock
dividend shall be proportionately increased, and the Exercise Price shall
be proportionately decreased, and in the event that the Company shall at
any time combine the outstanding shares of Common Stock, the number of
Warrant Shares issuable upon exercise of this Warrant immediately prior to
such combination shall be proportionately decreased, and the Exercise
Price shall be proportionately increased, effective at the close of
business on the date of such subdivision, stock dividend or combination,
as the case may be.
-3-
(c) Issuance of Additional Shares.
(i) If at any time while this Warrant is outstanding and after June 30, 2004,
the Company shall issue or sell any shares of its Common Stock (other than
Excluded Shares (as that term is defined below), "ADDITIONAL SHARES") in
exchange for consideration in an amount per Additional Share less than the
Exercise Price at the time the Additional Shares are issued or sold, then the
Exercise Price immediately prior to such issue or sale shall be reduced to a
price determined by dividing:
(1) an amount equal to the sum of (a) the number of shares of Common Stock
outstanding immediately prior to such issue or sale multiplied by the then
existing Exercise Price, plus (b) the consideration, if any, received by
the Company upon such issue or sale, by
(2) the total number of shares of Common Stock outstanding immediately
after such issue or sale.
(ii) The provisions of Section 3(c)(i) shall not apply to any deemed issuance of
Additional Shares for which an adjustment is provided under Section 3(a) or
3(b). No adjustment of the number of shares of Common Stock acquirable upon
exercise of this Warrant shall be made under Section 3(c) upon the issuance of
any shares of Common Stock which are issued pursuant to the exercise of any
warrants or other subscription or purchase rights or pursuant to the exercise of
any conversion or exchange rights in any convertible securities, if any such
adjustment shall previously have been made upon the issuance of such warrants or
other rights or upon the issuance of such convertible securities (or upon the
issuance of any warrant or other rights therefor) pursuant to Section 3(d).
For purposes of this Warrant the term "EXCLUDED SHARES" means: (i) shares of
Common Stock issuable or issued after the Closing Date to officers, employees,
consultants or directors of the Company directly or pursuant to a stock
purchase, stock option, restricted stock or other written compensation plan or
agreement approved by the Board of Directors of the Company (the "BOARD"); (ii)
shares of Common Stock issued or issuable after the Closing Date, primarily for
non-equity financing purposes and as approved by the Board, to financial
institutions or lessors in connection with commercial credit arrangements,
equipment financings or similar transactions or to vendors of goods or services
or customers; (iii) shares of Common Stock issuable upon (a) exercise of
warrants, options, notes or other rights to acquire securities of the Company,
in each case, outstanding on the issuance date of this Warrant (the "WARRANT
DATE"), (b) conversion of shares of the Company's Preferred Stock, par value
$0.01 per share, outstanding on the Warrant Date, (c) exchange of promissory
notes issued by the Company outstanding on the Warrant Date, (iv) the Shares (as
such term is defined Common Stock and Warrant Purchase Agreement, dated as of
the Warrant Date, among the Company and the persons and entities listed on
Schedule 1 thereto (the "PURCHASE AGREEMENT")); (v) the Warrants (as such term
is defined in the Purchase Agreement); (vi) capital stock or warrants or options
to purchase capital stock issued in connection with bona fide acquisitions,
mergers or similar transactions, the terms of which are approved by the Board;
-4-
(vii) shares of Common Stock issued or issuable to licensors of technology of
the Company to pay expenses, royalties or milestone payments for which the
Company is obligated under any licensing or related agreement; (viii) shares of
Common Stock issuable or issued pursuant to stock splits, stock dividends and
the like, or (ix) shares of Common Stock issued or issuable by way of dividend
or other distribution on Excluded Shares.
(d) Issuance of Common Stock Equivalents.
(i) If at any time while this Warrant is outstanding the Company shall
issue or sell any warrants or other rights to subscribe for or purchase
any additional shares of Common Stock or any securities convertible into
shares of Common Stock (other than the Additional Shares) (collectively,
"COMMON STOCK EQUIVALENTS"), whether or not the rights to exchange or
convert thereunder are immediately exercisable, and the effective price
per share for which Common Stock is issuable upon the exercise, exchange
or conversion of such Common Stock Equivalents shall be less than the
Exercise Price in effect immediately prior to the time of such issue or
sale, then the Exercise Price shall be adjusted as provided in Section
3(c) on the basis that the maximum number of additional shares of Common
Stock issuable pursuant to all such Common Stock Equivalents shall be
deemed to have been issued and outstanding and the Company shall have
received all of the consideration payable therefor, if any, as of the date
of the actual issuance of such Common Stock Equivalents. No further
adjustments to the current Warrant Price shall be made under this Section
3(d) upon the actual issue of such Common Stock upon the exercise,
conversion or exchange of such Common Stock Equivalents.
(ii) Upon the expiration or termination of any such Common Stock
Equivalents, the Exercise Price, to the extent in any way affected by or
computed using such Common Stock Equivalents, shall be recomputed to
reflect the issuance of the total number of shares of Common Stock (and
convertible or exchangeable securities which remain in effect) actually
issued upon the exercise, exchange or conversion of such Common Stock
Equivalents to the extent that this Warrant is then outstanding.
(e) Other Action Affecting Common Stock. In case at any time or from time to
time the Company shall take any action in respect of its Common Stock, other
than the payment of dividends permitted by Section 3 or any other action
described in Section 3, then, unless such action will not have a materially
adverse effect upon the rights of the Holder, the number of shares of Common
Stock or other stock into which this Warrant is exercisable and/or the purchase
price thereof shall be adjusted in such manner as may be equitable in the
circumstances.
(f) Certificate as to Adjustments. Upon the occurrence of each adjustment or
readjustment of the Exercise Price, the Company, at its expense, shall promptly
compute such adjustment or readjustment in accordance with the terms hereof and
prepare and furnish to the Holder of this Warrant a certificate setting forth
such adjustment or readjustment and showing in detail the facts upon which such
-5-
adjustment or readjustment is based. The Company shall, upon the written request
at any time of the Holder of this Warrant, furnish or cause to be furnished to
such Holder a like certificate setting forth (i) such adjustments and
readjustments, (ii) the Exercise Price at the time in effect and (iii) the
number of shares of Common Stock and the amount, if any, or other property which
at the time would be received upon the exercise of Warrants owned by such
Holder.
(g) Notice of Corporate Action. If at any time:
(i) the Company shall take a record of the holders of its Common
Stock for the purpose of entitling them to receive a dividend (other than
a cash dividend payable out of earnings or earned surplus legally
available for the payment of dividends under the laws of the jurisdiction
of incorporation of the Company) or other distribution, or any right to
subscribe for or purchase any evidences of its indebtedness, any shares of
stock of any class or any other securities or property, or to receive any
other right, or
(ii) there shall be any capital reorganization of the Company, any
reclassification or recapitalization of the capital stock of the Company
or any consolidation or merger of the Company with, or any sale, transfer
or other disposition of all or substantially all the property, assets or
business of the Company to, another corporation, or
(iii) there shall be a voluntary or involuntary dissolution,
liquidation or winding up of the Company;
then, in any one or more of such cases, the Company shall give to the
Holder (i) at least 10-days' prior written notice of the date on which a
record date shall be selected for such dividend, distribution or right or
for determining rights to vote in respect of any such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up, and (ii) in the case of any such
reorganization, reclassification, merger, consolidation, sale, transfer,
disposition, dissolution, liquidation or winding up, at least 10-days'
prior written notice of the date when the same shall take place. Such
notice in accordance with the foregoing clause also shall specify (i) the
date on which any such record is to be taken for the purpose of such
dividend, distribution or right, the date on which the holders of Common
Stock shall be entitled to any such dividend, distribution or right, and
the amount and character thereof, and (ii) the date on which any such
reorganization, reclassification, merger, consolidation, sale, transfer,
disposition, dissolution, liquidation or winding up is to take place and
the time, if any such time is to be fixed, as of which the holders of
Common Stock shall be entitled to exchange their shares of Common Stock
for securities or other property deliverable upon such reorganization,
reclassification, merger, consolidation, sale, transfer, disposition,
dissolution, liquidation or winding up. Each such written notice shall be
sufficiently given if addressed to the Holder at the last address of the
Holder appearing on the books of the Company and delivered in accordance
with Section 11(d).
(h) Adjustment if Registration Statement Not Effective. If a Registration
Statement (as defined in the Registration Rights Agreement, dated as of
the Warrant Date, among the Company and the persons and entities listed on
Schedule 1 thereto (the "REGISTRATION RIGHTS AGREEMENT")) is not effective
-6-
with respect to all the Registrable Securities (as defined in the
Registration Rights Agreement), other than Regisrtable Securities held by
holders (i) which have not complied with the Registration Rights
Agreement, including, without limitation, Section 4 thereof, or (ii) have
otherwise not permitted the Company to include such Registrable Securities
on the Registration Statement, on or prior to November 12, 2004, then the
Exercise Price shall be adjusted to equal $1.50 (subject to adjustment for
stock splits, reverse splits, stock dividends and the like, and subject to
adjustment in proportion to any adjustment pursuant to Section 3(c)).
4. TRANSFER OF WARRANT. This Warrant may only be transferred in compliance with
federal and state securities laws; provided, however, that the Company may
withhold its consent to transfer or assignment of this Warrant to any person or
entity who is deemed to be a competitor or prospective competitor of the
Company, such determination to be made in the reasonable judgment of the Board.
If, at the time of the surrender of this Warrant in connection with any transfer
of this Warrant or the resale of the Warrant Stock, this Warrant or the Warrant
Stock, as applicable, shall not be registered under the Securities Act, the
Company may require, as a condition of allowing such transfer (i) that the
Holder or transferee of this Warrant or the Warrant Stock as the case may be,
furnish to the Company a written opinion of counsel that is reasonably
acceptable to the Company to the effect that such transfer may be made without
registration under the Securities Act, (ii) that the Holder or transferee
execute and deliver to the Company an investment letter in form and substance
acceptable to the Company and substantially in the form attached as Exhibit B
hereto and (iii) that the transferee be an "accredited investor" as defined in
Rule 501(a) promulgated under the Securities Act. Transfer of this Warrant and
all rights hereunder, in whole or in part, in accordance with the foregoing
provisions, shall be registered on the books of the Company to be maintained for
such purpose, upon surrender of this Warrant at the principal office of the
Company or the office or agency designated by the Company, together with a
written assignment of this Warrant substantially in the form of Exhibit C hereto
duly executed by the Holder or its attorney-in-fact and funds sufficient to pay
any transfer taxes payable upon the making of such transfer. Upon such surrender
and, if required, such payment, the Company shall execute and deliver a new
Warrant or Warrants in the name of the assignee or assignees and in the
denomination specified in such instrument of assignment, and shall issue to the
assignor a new Warrant evidencing the portion of this Warrant not so assigned,
and this Warrant shall promptly be cancelled. Following a transfer that complies
with the requirements of this Section 4, the Warrant may be exercised by a new
Holder for the purchase of shares of Common Stock regardless of whether the
Company issued or registered a new Warrant on the books of the Company. This
Section 4 shall survive the exercise or expiration of the Warrant.
5. CONDITIONS TO EXERCISE OF WARRANT.
(a) Each certificate evidencing the Warrant Shares issued upon
exercise of this Warrant shall be stamped or imprinted with a legend
substantially in the following form:
THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE
SECURITIES ACT OF 1933 (THE "ACT") AND MAY NOT BE OFFERED, SOLD OR
OTHERWISE TRANSFERRED, PLEDGED OR HYPOTHECATED UNLESS AND UNTIL REGISTERED
UNDER THE ACT OR, IN THE OPINION OF COUNSEL IN FORM AND
-7-
SUBSTANCE SATISFACTORY TO THE ISSUER OF THESE SECURITIES, SUCH
OFFER, SALE OR TRANSFER, PLEDGE OR HYPOTHECATION IS IN COMPLIANCE
THEREWITH.
(b) REMOVAL OF LEGEND AND TRANSFER RESTRICTIONS. Any legend endorsed
on a certificate pursuant to this Section 5 shall be removed, and
the Company shall issue a certificate without such legend to the
holder of such Warrant Shares if (i) such Warrant Shares are resold
pursuant to a registration statement under the Securities Act of
1933, as amended, and a prospectus meeting the requirements of
Section 10 of the Securities Act is delivered or deemed delivered to
the purchaser of such Warrant Shares, (ii) if such holder satisfies
the requirements of Rule 144(k) or (iii) if such holder provides the
Company with an opinion of counsel for such holder of the Warrant
Shares, reasonably satisfactory to the Company, to the effect that a
sale, transfer or assignment of such Warrant Shares may be made
without registration. This paragraph shall survive any exercise of
this Warrant.
(c) RESTRICTIONS ON EXERCISE AMOUNT. Unless a Holder delivers to the
Company irrevocable written notice (x) prior to the date of issuance
hereof or 61 days prior to the effective date of such notice that
this Section 5(c) shall not apply to such Holder or (y) prior to a
Change of Control, the Holder may not acquire a number of Warrant
Shares to the extent that, upon such exercise, the number of shares
of Common Stock then beneficially owned by such Holder and its
affiliates and any other persons or entities whose beneficial
ownership of Common Stock would be aggregated with the Holder's for
purposes of Section 13(d) of the Securities Exchange Act of 1934, as
amended (the "EXCHANGE ACT"), (including shares held by any "group"
of which the Holder is a member, but excluding shares beneficially
owned by virtue of the ownership of securities or rights to acquire
securities that have limitations on the right to convert, exercise
or purchase similar to the limitation set forth herein) exceeds
9.99% of the total number of shares of Common Stock of the Company
then issued and outstanding. For purposes hereof, "group" has the
meaning set forth in Section 13(d) of the Exchange Act and
applicable regulations of the Securities Exchange Commission (the
"COMMISSION"), and the percentage held by the holder shall be
determined in a manner consistent with the provisions of Section
13(d) of the Exchange Act. Each delivery of a notice of exercise by
a Holder will constitute a representation by such Holder that it has
evaluated the limitation set forth in this paragraph and determined,
based on the most recent public filings by the Company with the
Commission, that the issuance of the full number of Warrant Shares
requested in such notice of exercise is permitted under this
paragraph.
6. FRACTIONAL SHARES. No fractional Warrant Shares will be issued in
connection with any exercise hereunder, but in lieu of such fractional
shares the Company shall make a cash payment therefor upon the basis of
the Exercise Price then in effect.
7. REGISTRATION RIGHTS. The Holder shall have the registration rights
described in the Registration Rights Agreement.
8. RIGHTS OF STOCKHOLDERS. No Holder shall be entitled, as a Warrant
holder, to vote or receive dividends or be deemed the holder of Warrant
Shares or any other securities of the Company which may at any time be
issuable on the exercise hereof for any purpose, nor shall anything
-8-
contained herein be construed to confer upon the Holder any of the rights
of a stockholder of the Company or any right to vote for the election of
directors or upon any matter submitted to stockholders at any meeting
thereof, or to give or withhold consent to any corporate action (whether
upon any recapitalization, issuance of stock, reclassification of stock,
change of par value, consolidation, merger, conveyance, or otherwise) or
to receive dividends or subscription rights or otherwise with respect to
the Warrant Shares until this Warrant shall have been exercised and the
Warrant Shares purchasable upon the exercise hereof shall have become
deliverable, as provided herein.
9. TERM OF WARRANT. This Warrant shall become exercisable on the Warrant
Date and shall no longer be exercisable as of the earlier of (i) 5:00
p.m., San Diego, California local time, on the date that is the five-year
anniversary of the Warrant Date; and (ii) upon consummation of a Change of
Control.
10. REDEMPTION AT COMPANY'S ELECTION. The Company may at the option of the
Board, by at least seven-days' prior written notice to the Holder (the
"REDEMPTION NOTICE"), redeem this Warrant, in whole or in part, at any
time after June 30, 2004, provided that (i) the Daily Market Price for
twenty consecutive trading days is equal to or greater than the product of
(x) 2 multiplied by (y) the Exercise Price, (ii) either (A) all of the
Warrant Shares underlying this Warrant to be redeemed are then registered
under an effective registration statement or (B) may be sold pursuant to
Rule 144 during a three-month period without registration under the
Securities Act, (iii) sufficient shares of Common Stock of the Company are
authorized and reserved for issuance upon the full exercise of this
Warrant, (iv) all of the Warrant Shares issuable upon exercise of this
Warrant are then listed on every stock exchange, market or bulletin board
on which any Common Stock of the Company is then listed and (v) the
Company is not in default of any material provision of any Transaction
Agreement (as defined in the Purchase Agreement). The Redemption Notice
shall set forth a date, not less than seven days after the date of the
Redemption Notice, on which the redemption of this Warrant shall occur
(the "REDEMPTION DATE"). On the Redemption Date, (i) the Company shall pay
the Holder by certified check an amount equal to the product of (x) $0.01
(as adjusted in proportion to any adjustment to the Exercise Price
pursuant to Section 3 hereof) multiplied by (y) the number of Warrant
Shares so redeemed; and (ii) the Holder shall deliver the original copy of
this Warrant marked "REDEEMED" to the Company. If the Company shall redeem
this Warrant in part, the Company shall, at the Redemption Date, provided
that the Holder shall have delivered the original copy of this Warrant
marked "REDEEMED" to the Company, deliver to the Holder a new Warrant
evidencing the rights of the Holder to purchase the unredeemed shares of
Common Stock called for by this Warrant, which new Warrant shall in all
other respects be identical with this Warrant. Nothing in this Section 10
shall prevent the exercise of the Warrants at any time prior to the
Redemption Date.
11. MISCELLANEOUS.
(a) This Warrant is being delivered in the State of California and
shall be construed and enforced in accordance with and governed by the
laws of the State of California, without giving effect to principles of
conflicts of laws.
-9-
(b) The headings in this Warrant are for purposes of reference only,
and shall not limit or otherwise affect any of the terms hereof.
(c) The terms of this Warrant shall be binding upon and shall inure
to the benefit of any successors or assigns of the Company and of the
Holder and of the Warrant Shares issued or issuable upon the exercise
hereof.
(d) Any notice provided for or permitted under this Warrant shall be
treated as having been given (a) upon receipt, when delivered personally
or sent by confirmed facsimile or telecopy, (b) one day after sending,
when sent by commercial overnight courier with written verification of
receipt, or (c) three business days after deposit with the United States
Postal Service, when mailed postage prepaid by certified or registered
mail, return receipt requested, addressed (a) if to the Company, at ▇▇▇▇
▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇, ▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇, facsimile: (▇▇▇) ▇▇▇-▇▇▇▇,
Attention: ▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇, or, if to the Holder, at such address or
facsimile number as the Holder shall have furnished to the Company in
writing, or at such other place of which the other party has been notified
in accordance with the provisions of this Section 11(d).
(e) This Warrant constitutes the full and entire understanding and
agreement between the parties with regard to the subjects hereof.
(f) Upon receipt of evidence reasonably satisfactory to the Company
of the loss, theft, destruction or mutilation of this Warrant and, in the
case of any such loss, theft or destruction, upon delivery of an indemnity
agreement reasonably satisfactory in form and amount to the Company or, in
the case of any such mutilation, upon surrender and cancellation of such
Warrant, the Company at the Holder's expense will execute and deliver to
the holder of record, in lieu thereof, a new Warrant of like date and
tenor.
(g) This Warrant and any provision hereof may be amended, waived or
terminated only by an instrument in writing signed by the Company and the
Holder.
(h) Receipt of this Warrant by the Holder shall constitute
acceptance of and agreement to the foregoing terms and conditions.
[Signature page follows.]
-10-
SIGNATURE PAGE TO THE A-1 WARRANT TO PURCHASE COMMON STOCK
IN WITNESS WHEREOF, the Company has caused this Warrant to be signed
by its duly authorized officer.
Issued: April __, 2004
ADVENTRX PHARMACEUTICALS, INC.
By: __________________________
▇▇▇▇▇▇▇▇ ▇. ▇▇▇▇▇
President & CEO
EXHIBIT A
NOTICE OF EXERCISE
TO: Adventrx Pharmaceuticals, Inc.
▇▇▇▇ ▇▇▇▇▇▇ ▇▇▇▇▇▇, ▇▇▇▇▇ ▇▇▇
▇▇▇ ▇▇▇▇▇, ▇▇ ▇▇▇▇▇
1. The undersigned hereby elects to purchase _____shares of Common
Stock, par value $0.001 per share, of the Company ("COMMON STOCK") pursuant to
the terms of Section 1(b) of the A-1 Warrant to Purchase Common Stock dated
______ 2004 (the "WARRANT"), and tenders herewith payment of the purchase price
of such shares in full.
2. The undersigned hereby elects to convert the attached Warrant
into Common Stock of Adventrx Pharmaceuticals, Inc. through "cashless exercise"
in the manner specified in the Warrant. This conversion is exercised with
respect to _________ of the Shares covered by the Warrant.
Please issue a certificate or certificates representing said ______
shares of Common Stock in the name of the undersigned or in such other name as
is specified below:
Name: ---------------------------------
Address:
---------------------------------
---------------------------------
The undersigned hereby represents and warrants that the aforesaid
shares of Common Stock are being acquired for the account of the undersigned for
investment and not with a view to, or for resale, in connection with the
distribution thereof, and that the undersigned has no present intention of
distributing or reselling such shares, and that all representations and
warranties of the undersigned with respect to the Warrant and Warrant Shares (as
defined in the Warrant) set forth in Section 4 of the Purchase Agreement (as
defined in the Warrant) were true and correct as of the Warrant Date (as defined
in the Warrant) and are true and correct as of the date hereof.
By:
------------------
Name:
------------------
Title:
------------------
Date:
------------------
-21-
EXHIBIT B
FORM OF INVESTMENT REPRESENTATION LETTER
In connection with the acquisition of [warrants (the "Warrants") to purchase
shares of Common Stock of Adventrx Pharmaceuticals, Inc. (the "Company"), par
value $0.001 per share (the "Common Stock")][________ shares of Common Stock of
Adventrx Pharmaceuticals, Inc. (the "Company"), par value $0.001 per share (the
"Common Stock")], by
represents and warrants to the Company as follows:
The Holder (i) is an "Accredited Investor" as that term is defined in Rule 501
of Regulation D promulgated under the Securities Act of 1933, as amended (the
"Act"); and (ii) has the ability to bear the economic risks of such Holder's
prospective investment, including a complete loss of Holder's investment in the
Warrants and the shares of Common Stock issuable upon the exercise thereof
(collectively, the "Securities").
The Holder, by acceptance of the Warrants, represents and warrants to the
Company that the Warrants and all securities acquired upon any and all exercises
of the Warrants are purchased for the Holder's own account, and not with view to
distribution of either the Warrants or any securities purchasable upon exercise
thereof in violation of applicable securities laws.
The Holder acknowledges that (i) the Securities have not been registered under
the Act, (ii) the Securities are "restricted securities" and the certificate(s)
representing the Securities shall bear the following legend, or a similar legend
to the same effect, until (i) in the case of the shares of Common Stock
underlying the Warrants, such shares shall have been registered for resale by
the Holder under the Act and effectively been disposed of in accordance with a
registration statement that has been declared effective; or (ii) in the opinion
of counsel for the Company such Securities may be sold without registration
under the Act:
"[NEITHER] THE SECURITIES REPRESENTED BY THIS CERTIFICATE [NOR THE SECURITIES
INTO WHICH THEY ARE EXERCISABLE] HAVE [NOT] BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED (THE "ACT"), AND ALL SUCH SECURITIES ARE SUBJECT TO
RESTRICTIONS ON TRANSFERABILITY AS SET FORTH IN THIS CERTIFICATE. [NEITHER] THE
SECURITIES REPRESENTED HEREBY [NOR THE SECURITIES INTO WHICH THEY ARE
EXERCISABLE] MAY [NOT] BE SOLD, TRANSFERRED, OR OTHERWISE DISPOSED OF IN THE
ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT UNDER THE ACT OR AN OPINION OF
COUNSEL, REASONABLY ACCEPTABLE TO COUNSEL FOR THE COMPANY, TO THE EFFECT THAT
THE PROPOSED SALE, TRANSFER, OR DISPOSITION MAY BE EFFECTUATED WITHOUT
REGISTRATION UNDER THE ACT."
IN WITNESS WHEREOF, the Holder has caused this Investment Representation Letter
to be executed in its corporate name by its duly authorized officer this __ day
of __________ 200__.
[Name]
By:______________________________
Name:
Title:
EXHIBIT C
ASSIGNMENT FORM
FOR VALUE RECEIVED the undersigned registered owner of this Warrant for the
purchase of shares of Common Stock of Adventrx Pharmaceuticals, Inc. hereby
sells, assigns and transfers unto the Assignee named below all of the rights of
the undersigned under this Warrant, with respect to the number of shares of
common stock set forth below:
---------------------------------------
---------------------------------------
---------------------------------------
(Name and Address of Assignee)
---------------------------------------
(Number of Shares of Common Stock)
and does hereby irrevocably constitute and appoint ____________ attorney-in-fact
to register such transfer on the books of the Company, maintained for the
purpose, with full power of substitution in the premises.
Dated:_________________________________
--------------------------------------
(Print Name and Title)
--------------------------------------
(Signature)
--------------------------------------
(Witness)
NOTICE: The signature on this assignment must correspond with the name as
written upon the face of the Warrant in every particular, without alteration or
enlargement or any change whatsoever.